For end-stage retinopathy, vitrectomy will also remain ... GH inhibitors, corticosteroids (triamcinolone acetonide, fluocinolone acetonide and dexamethasone), intravitreal injections of anti ...

Proliferative diabetic retinopathy is clinically characterized ... the intravitreal injection or implantation of steroids (triamcinolone acetonide, dexamethasone, fluocinolone acetonide, and ...

Treating diabetic retinopathy (DR) is still a significant challenge for clinicians and remains a leading cause of blindness worldwide. NovaGo Therapeutics is developing a human antibody therapy ...

The risks of stroke and mortality from stroke are increased in patients with diabetes. Diabetic retinopathy is common in diabetic individuals, but studies of the association between this ...